Alcon AG | ALC - Operating Expenses


Alcon AG reported $2.41B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
AstraZeneca USD 12.22B 4.04B Jun/2026
Bayer EUR 9.88B 452M Mar/2026
Essilor EUR 12.52B 568M Jun/2026
Fresenius EUR 5.23B 9M Jun/2026
Fresenius Medical Care EUR 4.34B 63M Mar/2026
GlaxoSmithKline GBP 5.8B 468M Jun/2026
GRIFOLS EUR 1.55B 94M Jun/2026
Lonza CHF 2.9B 184M Jun/2025
Merck EUR 4.09B 687M Mar/2026
Novartis USD 10.2B 912M Jun/2026
Philips EUR 3.75B 147M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 9.92B 607M Jun/2026
Smith & Nephew USD 2.59B 71M Jun/2026
Sonova Holding CHF 1.52B 59.9M Dec/2025
UCB EUR 2.96B 196M Dec/2025